| Literature DB >> 24957352 |
David J Weldon1, Marilyn D Saulsbury2, Joshua Goh1, Leah Rowland3, Petreena Campbell3, Laijia Robinson4, Calvin Miller1, Joshua Christian1, Louisa Amis3, Nia Taylor3, Cassandra Dill3, Willie Davis5, Stanley L Evans6, Eileen Brantley7.
Abstract
A series of cinnamylideneacetophenones were synthesized via a modified Claisen-Schmidt condensation reaction and evaluated for cytotoxicity against breast cancer cells using the Alamar Blue™ assay. Derivatives 17 and 18 bearing a 2-nitro group on the B ring, exhibited sub-micromolar cytotoxicity in MCF-7 cells (IC50=71 and 1.9 nM), respectively. Derivative 17 also displayed sub-micromolar (IC50=780 nM) cytotoxicity in MDA-MB-468 cells. Additionally, 17 and 18 displayed significantly less cytotoxicity than the chemotherapeutic doxorubicin in non-tumorigenic MCF-10A cells. This study provides evidence supporting the continued development of nitro-substituted cinnamylideneacetophenones as small molecules to treat breast cancer.Entities:
Keywords: Breast cancer; Chalcone derivatives; Cytotoxicity; Estrogen receptor; Leinamycin
Mesh:
Substances:
Year: 2014 PMID: 24957352 PMCID: PMC4145842 DOI: 10.1016/j.bmcl.2014.05.089
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823